Distinct cytokine profiles of systemic-onset juvenile idiopathic arthritis-associated macrophage activation syndrome with particular emphasis on the role of interleukin-18 in its pathogenesis.
about
Making sense of the cytokine storm: a conceptual framework for understanding, diagnosing, and treating hemophagocytic syndromesSerum cytokine profile in pediatric Sweet's syndrome: a case report.Pathogenesis of adult-onset Still's disease: new insights from the juvenile counterpart.Treatment of adult-onset Still's disease: a reviewAn activating NLRC4 inflammasome mutation causes autoinflammation with recurrent macrophage activation syndromePathogenesis of systemic juvenile idiopathic arthritis: some answers, more questions.The hyperferritinemic syndrome: macrophage activation syndrome, Still's disease, septic shock and catastrophic antiphospholipid syndromeSerum neopterin levels as a diagnostic marker of hemophagocytic lymphohistiocytosis syndrome.Successful control of juvenile dermatomyositis-associated macrophage activation syndrome and interstitial pneumonia: distinct kinetics of interleukin-6 and -18 levelsEvidence-based diagnosis and treatment of macrophage activation syndrome in systemic juvenile idiopathic arthritis.The limited role of interferon-γ in systemic juvenile idiopathic arthritis cannot be explained by cellular hyporesponsivenessReview of biomarkers in systemic juvenile idiopathic arthritis: helpful tools or just playing tricks?Update on the pathogenesis and treatment of systemic idiopathic arthritis.Not all hemophagocytes are created equally: appreciating the heterogeneity of the hemophagocytic syndromes.What do cytokine profiles tell us about subsets of juvenile idiopathic arthritis?Macrophage activation syndrome and cytokine-directed therapies.Hyperinflammation, rather than hemophagocytosis, is the common link between macrophage activation syndrome and hemophagocytic lymphohistiocytosis.Pathogenesis of macrophage activation syndrome and potential for cytokine- directed therapies.Complications of systemic juvenile idiopathic arthritis: risk factors and management recommendations.Macrophage activation syndrome in the course of monogenic autoinflammatory disorders.Therapeutic Potential of Interferon-γ and Its Antagonists in Autoinflammation: Lessons from Murine Models of Systemic Juvenile Idiopathic Arthritis and Macrophage Activation Syndrome.Inflammatory Gene Expression Profile and Defective Interferon-γ and Granzyme K in Natural Killer Cells From Systemic Juvenile Idiopathic Arthritis Patients.Macrophage activation syndrome in the era of biologic therapy.Review: Cytokine Storm Syndrome: Looking Toward the Precision Medicine Era.New frontiers in the treatment of systemic juvenile idiopathic arthritis.Characteristic elevation of soluble TNF receptor II : I ratio in macrophage activation syndrome with systemic juvenile idiopathic arthritis.Interferon-γ mediates anemia but is dispensable for fulminant toll-like receptor 9-induced macrophage activation syndrome and hemophagocytosis in mice.Monitoring serum IL-18 levels is useful for treatment of a patient with systemic juvenile idiopathic arthritis complicated by macrophage activation syndrome.Primary varicella infection in children with systemic juvenile idiopathic arthritis under tocilizumab therapy.Rate and Clinical Presentation of Macrophage Activation Syndrome in Patients With Systemic Juvenile Idiopathic Arthritis Treated With Canakinumab.Paediatric rheumatic disease: Diagnosing macrophage activation syndrome in systemic JIA.Cytokine profiles in children with primary Epstein-Barr virus infection.Serum IL-18 as a potential specific marker for differentiating systemic juvenile idiopathic arthritis from incomplete Kawasaki disease.Overview of the IL-1 family in innate inflammation and acquired immunity.M-CSF induces the expression of a membrane-bound form of IL-18 in a subset of human monocytes differentiating in vitro toward macrophages.Weathering the storm: Improving therapeutic interventions for cytokine storm syndromes by targeting disease pathogenesis.Interleukin-18 diagnostically distinguishes and pathogenically promotes human and murine macrophage activation syndrome.Serum ferritin levels as a useful diagnostic marker for the distinction of systemic juvenile idiopathic arthritis and Kawasaki disease.Macrophages and the Recovery from Acute and Chronic Inflammation.Elevated circulating levels of interferon-γ and interferon-γ-induced chemokines characterise patients with macrophage activation syndrome complicating systemic juvenile idiopathic arthritis.
P2860
Q27011625-CD9C8A3C-4A4D-4E3B-B7F8-321FD89AA890Q33862602-57283572-AE15-4A31-87B2-7F71B18C0332Q34042413-1276E2E1-0C21-4653-B0A2-B1C8F1E744CDQ34043097-837CB88D-BC3E-4D7C-8CCA-9348DD0E44CBQ34254955-1BDCF60C-AA4A-43F5-8651-95E80B0F3654Q34269827-DB9CE1A6-B285-4FB4-A96D-53CA9E8C6D87Q34966670-8EE9A436-5B94-4F7B-8D25-61E4BDB79A8AQ35066319-EB599A5C-74C0-4160-A495-3ACE46718425Q36298454-30550AAC-DD76-428A-9C7F-B6960E483184Q36346681-51C4FADC-AA4E-40A9-8E1C-7AF93A51A099Q36351200-021F9C5D-9839-4381-81B5-129EE4FFC21FQ37093920-22037EC5-C2A0-4DE9-813B-51D3C40FEE14Q37951816-BC03605B-882C-4322-BFB9-C45A9E1D0A38Q37956870-10051454-277E-4968-8FF2-58CBF44D43ACQ37975164-6572C6B3-98EA-4D4A-B777-54874F74CE5BQ38224085-4ADD0C60-C760-431B-B2DF-E7F77A219F96Q38229212-2087974A-F665-40D4-A7DF-23B48E75E52CQ38267068-ED65724E-ED6C-4F46-B15E-9D72D470B8EAQ38406386-68D153F7-09CB-4B58-A5CC-FDCB06ACB666Q38408014-965A1EAF-3C83-4AFC-AC68-1794996169B6Q38648790-25C09439-944D-4321-BA10-8E58888B0601Q38742750-05EC1B7F-AE61-4CBE-B206-25E6C6B6B4ABQ38786756-1B7EEF24-5ACE-4C32-BB91-68E946F3B149Q39144075-A37CEE65-6F8C-4688-9C65-7975B20DB9E4Q39424746-94F0D563-8B94-4612-8EB1-13DB40CB3235Q40080398-1C98ECAA-0EAC-4583-A61E-AA9E4D5B6200Q40252348-92D383D9-FFAE-4467-94DF-5FB3D66D9A42Q40318743-A997A077-4020-4252-86C9-9426BE9A8E0AQ40450982-B1446450-2A3B-40CC-ABF6-25CED08E23A2Q41029387-91943824-7A1E-4243-A7F7-B71873B1C291Q41747703-554CB04F-C039-4489-BCD3-D9E67133BCC8Q42276348-D2FC265C-2D7B-48AF-A135-A89C81AED534Q46945967-3A7CA539-BC21-483F-98E8-8E23ABF13A22Q47285878-A305361E-1F63-4DF1-8EFC-EE6EEDBC7E62Q47649630-1FBA6AFA-4BC2-435C-8FA7-21B582CE4752Q47931407-BB1251E4-2A9C-40EE-B2A4-D2DF6BA5DAC9Q48258109-D0CD0653-F475-4277-B7A4-85A2CF8AC065Q50234930-6AF96385-6578-4AEA-9836-683994E26A8EQ51270292-CC2FB2D5-7A9C-48AE-A71A-32A16CB6F0F7Q51705351-47787130-140F-4719-A0E7-79123F2F3407
P2860
Distinct cytokine profiles of systemic-onset juvenile idiopathic arthritis-associated macrophage activation syndrome with particular emphasis on the role of interleukin-18 in its pathogenesis.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
Distinct cytokine profiles of ...... leukin-18 in its pathogenesis.
@en
Distinct cytokine profiles of ...... leukin-18 in its pathogenesis.
@nl
type
label
Distinct cytokine profiles of ...... leukin-18 in its pathogenesis.
@en
Distinct cytokine profiles of ...... leukin-18 in its pathogenesis.
@nl
prefLabel
Distinct cytokine profiles of ...... leukin-18 in its pathogenesis.
@en
Distinct cytokine profiles of ...... leukin-18 in its pathogenesis.
@nl
P2093
P2860
P921
P356
P1433
P1476
Distinct cytokine profiles of ...... leukin-18 in its pathogenesis.
@en
P2093
Akihiro Yachie
Hideo Wada
Hisashi Kaneda
Kazuhide Ohta
Keiko Yamada
Masaki Shimizu
Tadafumi Yokoyama
Taizo Wada
Tomoko Toma
Yoshihito Kasahara
P2860
P304
P356
10.1093/RHEUMATOLOGY/KEQ133
P577
2010-05-14T00:00:00Z